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A B S T R A C T
While triploid Atlantic salmon represent a practical and affordable solution to the issues associated with sexual
maturation in the salmonid aquaculture industry, empirical evidence suggests triploids are more susceptible to
disease and vaccine side-effects than diploids. With vaccination now part of routine husbandry, it is essential
their response be studied to confirm their suitability for commercial production. This study tested the response of
triploid and diploid Atlantic salmon to vaccination with commercially available vaccines. Triploid and diploid
Atlantic salmon siblings were injected with one of three commercial vaccines (or sham-vaccinated) and mon-
itored for performance throughout a commercial production cycle. Sampling at smolt and harvest was under-
taken along with individual weight and length assessments through the cycle. Antibody response to Aeromonas
salmonicida vaccination was similar in both ploidy, with a positive response in vaccine-injected fish. For both
adhesions and melanin, analysis found that higher scores were more likely to occur as the anticipated severity of
the vaccine increased. In addition, for adhesion scores at smolt and melanin scores at smolt and harvest, triploids
were statistically more likely to exhibit high scores than diploids. Triploids maintained a significantly higher
body weight during freshwater and until 11 months post-seawater transfer, with diploids weighing significantly
more at harvest. Growth, represented by thermal growth coefficient (TGC), decreased in both ploidy as the
severity of adhesions increased, and regression patterns did not differ significantly between ploidy. Vertebral
deformity prevalence was consistently higher in triploids (smolt 12.3 ± 4.5%; harvest 34.9 ± 5.9%) than
diploids (smolt 0.8 ± 0.5%; harvest 15.9 ± 1.9%), with no significant difference between vaccine groups in
each ploidy. This study demonstrates that triploids respond as well to vaccination as diploids and provides
further supporting evidence of triploid robustness for commercial aquaculture.
1. Introduction
Disease is considered one of the most significant constraints to the
continued development and success of Atlantic salmon aquaculture,
with substantial economic losses caused by increased mortalities,
downgrading at harvest and treatment use [1,2]. The aquaculture in-
dustry has employed numerous strategies to prevent disease outbreaks
in intensive farming including improved biosecurity procedures (using
reliable egg/fish stocks; water quality monitoring; disinfection of ve-
hicles and equipment) and the implementation of diagnostic tools for
early pathogen detection [2–4]. However, many pathogens form part of
the ubiquitous and otherwise benign aquatic microfauna and only be-
come pathogenic when the fish are subjected to unfavourable condi-
tions acting as stressors [2,5–7]. The treatment for many of these pa-
thogens has been limited to antibiotics and chemotherapeutics but, over
the years, extensive use has resulted in the development of pathogen
resistance to the once effective products [8–12]. With prevention re-
garded better than a cure, vaccination has become the single most
important tool for disease control in the aquaculture industry, with
research since the late 1930's resulting in the production of numerous
effective aquatic vaccines [13–17].
However, vaccination may reduce growth and result in side-effects,
including adhesions and increased vertebral deformity prevalence
which impact negatively on fish health and welfare as well as produc-
tion quality [18–22]. Adhesions form adjacent to the injection site and,
if severe, can connect organs firmly to the peritoneum and cause da-
mage to the muscle upon removal [22–24]. Vertebral deformities can
be evident prior to vaccination but inflammation around the spine, as a
result of vaccination and the associated handling has been suggested to
aggravate vertebral deformities post-vaccination [21,25–27].
Triploid Atlantic salmon (Salmo salar) have long been considered as
a method to prevent early sexual maturation and the associated
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negative impacts on fish performance prior to harvest in aquaculture
[28,29]. Over the last decade, numerous advances have been made in
triploid research, with studies demonstrating triploid salmon have
many different requirements to diploids, including a lower thermal
optimum and higher requirements for key nutrients including phos-
phorus and histidine [30–36]. However, there continues to be limited
data regarding the response of triploid Atlantic salmon to disease and
disease treatments with historical and empirical reports suggesting an
increased susceptibility in triploids. Following experimental challenge
with Renibacterium salmoninarum, diploid and triploid Atlantic salmon
were found to be similarly susceptible to the pathogen [37], with
challenge by Aeromonas salmonicida eliciting similar levels of mortality
and antibody responses between ploidy [38]. In response to challenges
with viral (salmon alphavirus) and parasitic (Lepeophtheirus salmonis;
Neoparamoeba perurans) pathogens, infection rates and severity were
similar in both ploidy, with comparable mortality observed during
parasite challenges [39–41]. While these studies demonstrate similar
susceptibility to controlled disease challenges, few studies to date have
investigated the response of triploid Atlantic salmon to vaccination.
Vaccination with ALPHA-JECT 2-2 (PHARMAQ AS) produced si-
milar adhesion scores in diploid and triploid Atlantic salmon and had
no significant effect on weight [38]. Intraperitoneal administration of
MINOVA 6 Vet (Norvax®, Intervet International B.V., Boxmeer, Neth-
erlands) negatively impacted on growth in S1+ diploid and triploid
Atlantic salmon smolts, although no other side-effects were assessed in
this study [42]. A follow up study by Fraser et al. [43] using diploid and
triploid Atlantic salmon with both S0+ and S1+ smolt groups, again,
showed a negative effect of vaccination with MINOVA 6 Vet on weight.
Significantly higher adhesion scores were also found in triploid S0+
smolts compared to their diploid sibling group, while no ploidy effect
was found in S1+ smolts. Within diploids and triploids under both
smolt regimes, vaccination did not have a direct impact on prevalence
or severity of vertebral deformities [43]. Between ploidy, however,
triploid S1+ smolts had significantly higher levels of vertebral defor-
mity than their diploid siblings, while no ploidy effect was observed in
the S0+ smolts. The authors hypothesised that, while S0+ production
is considered as a risk factor due to the known correlation between
increased growth rates at high temperatures and vertebral deformity
development [44,45], the elevated temperatures in S0+ production
may have impeded growth rates in triploids thus alleviating the risk of
fish developing severe vertebral deformities.
These studies highlight that vaccination can impact the performance
and health of triploids, as well as diploids, although they were rela-
tively limited in their assessment of adhesions and deformities as side-
effects with a focus on only two vaccines. Considering the benefits as-
sociated with the use of triploids in commercial aquaculture production
and the almost universal adoption of vaccination of farmed Atlantic
salmon, it is essential that studies be undertaken to elucidate the tol-
erance of triploids to the vaccination process as well as the associated
side-effects.
The aim of this study was to compare the response of triploid and
diploid Atlantic salmon to a range of commercially available vaccines,
including an “accidental double-dose”, and assess side-effects in terms
of performance, the development of abdominal adhesions and occur-
rence of vertebral deformities.
2. Materials and methods
2.1. Fish stock and history
On 23rd October 2015, eggs and milt were stripped from unrelated
2-sea winter Atlantic salmon broodstock (20 dams & 5 sires; strain PD-
Strong, Mowi, Tveitvag, MOWI Norway). Following fertilisation, half of
each egg batch was subjected to a pressure shock of 655 bar for
6.25 min, applied at 37.5 min post-fertilisation at 8 °C (TRC-APV; Aqua
Pressure Vessel, TRC Hydraulics Inc., Dieppe, NB, Canada) to induce
triploidy. Water hardened eggs were then incubated in six upwelling
silos (3 ploidy−1) at 6.7 °C (temperature range: 5.4 °C–7.0 °C) until
automatic sorting. Survival at sorting was 88% and 85% for diploid and
triploid ova, respectively. Eyed ova were delivered to Howietoun
Hatchery, Sauchieburn, Stirling on 16th December 2015 (353 °D post-
fertilisation). Eggs were then incubated in mesh trays in a flow-through
system at 7.0 ± 0.3 °C in 6 × 300 L square fibreglass tanks (5000 eggs
ploidy−1, 1 m2, 0.3 m depth) in darkness until first feeding (26th
February 2016). Mortality from egg receipt to first feeding was 5.1%
and 6.5% for diploids and triploids, respectively. At first feeding, fry
were reared under constant light and fed a commercial diet (diploids -
Inicio Plus; triploids – Inicio-TriX, BioMar UK), distributed by auto-
matic feeders (Arvo-Tec Oy, Finland). When approximately 0.5 g, fry
were divided evenly between 12 × 300 L to reduce stocking density.
On 11th May 2016, all fry (~1.22 g) were transferred from the hatchery
to the Niall Bromage Freshwater Research Facility (NBFRF),
Buckieburn, and stocked into two flow-through 28 m3 holding tanks (1
ploidy−1), and exposed to a continuous light (LL) photoperiod prior to
the start of the experiment. Tanks were maintained at ambient tem-
perature (10–15 °C) (Fig. 1). Specific feeding rates (% tank biomass per
day) were adjusted automatically according to predicted growth and
daily temperature, and pellet size (0.5–2.0 mm) increased with fish size.
Prior to the start of the experiment (8th August 2016), both stock tanks
were graded (5th August 2016) using a box grader (12 mm bar,
STERNER AquaTech) to remove the bottom grade.
2.2. Experimental design
On 8th August 2016, diploid (18.6 ± 0.3 g) and triploid
(25.4 ± 0.4 g) Atlantic salmon were stocked into six lightproof 1.6 m3
circular (2 m diameter) tanks (3 tanks ploidy−1, 350 fish tank−1) and
maintained under an LL photoperiod. On 17th August 2016, all fish (350
fish tank−1) were individually tagged using Trovan® (Trovan Ltd, UK)
and Pet ID (Pet ID Microchips Ltd., West Sussex, UK) passive integrated
transponder (P.I.T) tags for identification throughout the trial.
Mortality between P.I.T tagging and vaccination was 1.67% for diploids
and 1.09% for triploids. Following tagging, all tanks were subjected to a
“winter” (LD 12:12) photoperiod for 5 weeks, before being returned to
LL (26th September 2016) for ~400 °D to induce S0+ smoltification,
prior to seawater transfer (7th – 8th November 2016).
From 6th to 8th September 2016 (average temperature 15.3 °C), all
experimental fish were vaccinated (diploids: 44.2 ± 0.7 g; triploids:
57.8 ± 1.6 g; p = 0.002). All fish were anaesthetised with Tricaine
(50 ppm, PHARMAQ, Norway) and then seventy fish per tank were
intraperitoneally injected with either 0.02 M phosphate buffered saline
(PBS; Group A), ALPHA JECT 2-2 (Group B), ALPHA JECT micro 6
(Group C), ALPHA JECT 6-2 (Group D) or ALPHA JECT 6-2 (double
dose) (Group Dx2) using either a FISHJECTOR 0.1 ml or a MICROFISH
0.05 ml vaccine gun (Kaycee Veterinary Products Ltd., West Sussex,
UK) depending on the dose (Table 1). At the time of vaccination, the
body weight (g) and fork length (mm) of each fish was recorded. Fol-
lowing vaccination, all fish were returned to the appropriate trial tank
for recovery and were maintained in these tanks for 52 days (622 °D)
until sampling.
On 7th and 8th November, following “smolt” sampling, all re-
maining experimental Atlantic salmon (diploids 638; triploids 643)
were transferred to triplicate sea-cages (5 m height x 5 m width x 5 m
depth; net mesh 18 mm) at the Ardnish Feed Trial Unit (Lochailort,
MOWI, Scotland, UK). Fish remained in the sea-cages under ambient
light and water temperature (Fig. 1) until January 2018 at which time
the trial was terminated and “harvest” sampling took place. Specific
feeding rates (% cage biomass per day) were adjusted automatically
according to predicted growth and daily temperature, and pellet size
(3.5–12 mm in SW) increased with fish size and were distributed by
automatic feeders (Arvo-Tec Oy, Finland). Fish were fed commercial
seawater diets (diploids – BioMar CPK; triploids – BioMar CPK-TriX,
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BioMar UK) and daily waste feed was collected by siphon uplifts per
pen.
2.3. Sampling
2.3.1. Freshwater – Smolt
“Smolt” sampling was undertaken on 6 consecutive days from 31st
October 2016, with one full tank sampled per day, alternating between
triploids and diploids. Fish were removed from the experimental tank
and maintained in 300 L holding tanks for the duration of the sampling,
with water aerated throughout (average temperature 8.6 °C). All fish
were anaesthetised with 50 ppm Tricaine (PHARMAQ, PHARMAQ Ltd.)
then the individual P.I.T tag number, body weight (g) and fork length
(mm) recorded. Condition factor (K) [46] was calculated using:
K = 100 x W/L3; where W is body weight (g) and L is fork length (mm).
Thermal growth coefficient (TGC) [47] from vaccination to smolt, and
then from smolt to harvest was calculated using: TGC = 1000 x (W21/3
– W11/3)/(T x t); where W1 is the initial weight for the period and W2 is
the final weight, T is temperature in °C and t is time in days. As P.I.T
tags were scanned, 25 fish vaccine group−1 tank−1 were culled
(1000 ppm Tricaine and percussive blow to the head) for further
sampling. Following sampling, all non-tissue sampled fish (approx. 225
tank−1) were returned to the experimental tank for recovery.
From culled fish, blood samples were obtained from the caudal vein
using a non-heparinised needle and syringe and kept at 4 °C for 24 h.
Samples were then centrifuged at 3000 g for 10 min before serum was
collected and stored at −20 °C until determination of antibody re-
sponse. The severity of intra-abdominal adhesions in the peritoneal
cavity was scored visually according to the Speilberg scale [48]. For
this, the peritoneal cavity was divided into three regions and a score
given to each:
• Region 1: Anterior and anterior-dorsal parts of abdominal cavity
including oesophagus, liver and anterior parts of the swim bladder• Region 2: Posterior and posterior-dorsal parts of abdominal cavity
including hind gut• Region 3: Ventral region of abdomen close to the recommended
injection site
Table 1
Vaccine component details, delivered dose and anticipated adhesion score severity for the five experimental groups.
Group Vaccine Dose volume (μl) Vaccine components Anticipated adhesion scorea
A PBS 100 Acting as sham-vaccinated control group 0
B ALPHA JECT 2-2 100 Aeromonas salmonicida subsp. salmonicida; IPNV serotype Sp 1.3
C ALPHA JECT micro 6 50 A. salmonicida subsp. salmonicida;
Listonella anguillarum serotypes O1 & O2a;
Vibrio salmonicida; Moritella viscosa;
IPNV serotype Sp
1.5
D ALPHA JECT 6-2 100 A. salmonicida subsp. salmonicida;
L. anguillarum serotypes O1 & O2a;
V. salmonicida; M. viscosa; IPNV serotype Sp
2.2
Dx2 ALPHA JECT 6-2 (double-dose) 200 As above; acting as “accidental double dose injection” scenario 5
a Anticipated adhesion scores were calculated by PHARMAQ (Zoetis LLC, New Jersey, USA) using vaccine validation and test data, number of antigens and dose
volume to give an increasing scale of severity, according to anticipated adhesion scores.
Fig. 1. Temperature profile for the duration of the experimental trial (August 2016 to January 2018). Dashed line indicates seawater transfer. Black arrows indicate
1) P.I.T tagging, 2) “winter” (LD12:12) photoperiod applied, 3) vaccination, 4) LL photoperiod re-applied to induce smoltification 5) smolt sampling, 6) May weight
assessment, 7) August weight assessment, 8) October weight assessment, 9) harvest sampling.
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For analysis, the highest score across the three zones was taken as
the overall adhesion score. In addition, melanin deposits on the viscera
were scored according to Pharmaq (Zoetis) (Table 2) [49].
Radiographs of each fish were then obtained using a device cabinet
x-ray radiography unit (FaxinTron UltraFocus, Daax Ltd, USA; 24 kV,
mAs: 5.0) and digital images were generated as dicom files for further
analysis.
2.3.2. Seawater sampling
Following transfer to seawater, individual weight (± 1 g) and
length (± 1 mm) assessments were undertaken at the Ardnish Feed
Trial Unit on 19th May 2017 (192 days, 1586 °D post-transfer), 10th
August 2017 (283 days, 2722 °D post-transfer) and 6th October 2017
(331 days, 3439 °D post-transfer). Fish were anaesthetised (50 ppm
Tricaine) before individual P.I.T tag, weight and length were recorded.
Fish were returned immediately to the sea-cage for recovery.
Final “harvest” sampling was undertaken on 6 consecutive days
from 11th January 2018. All remaining fish were terminally culled
(1000 ppm MS-222 then percussive blow to the head). Following P.I.T
tag identification, individual body weight and fork length was recorded.
Condition factor (K) and TGC between smolt and harvest were calcu-
lated as previously described. Adhesions and melanin deposits were
scored in all fish (200 sea-cage−1), as previously described.
Furthermore, radiographs of 20 fish vaccine group−1 sea-cage−1 were
obtained using a portable x-ray unit (Celtic SMR PX40 HF; 32 mAs;
40 kV) and AGFA XenOR 35CL detector plate, with digital images
generated as Dicom files for pathology interpretation.
2.4. X-ray radiograph for vertebral deformities
Dicom images of each fish were analysed for vertebral deformities
(RadiAnt Dicom Viewer software, Medixant, Poland). For each fish,
total vertebrae number along with the location and deformed vertebrae
(dV) pathology type [50] were recorded. Subsequently, pathologies
were grouped together into decreased intervertebral space (type 1),
compression (types 2, 3, 4 and 5), fusion (types 6, 7 and 8), radiodense
(types 12 and 13), symmetry (types 17 and 19) and other (types 9, 10
and 11). For analysis, the vertebral column was divided into four re-
gions (R): R1 (cranial trunk, V1 - 8), R2 (caudal trunk, V9 - 30), R3 (tail,
V31 - 49) and R4 (tail fin, V50 – end) [51]. In consideration of the
findings from Hansen et al. [44], x-rays were also classified according
to severity in terms of number of dV. If 1–5 dV were observed, this was
defined as “mild”, with ≥6 dV considered “moderate – severe and
likely to affect welfare”. For statistical analysis, only fish classed as
“moderate - severe” were assessed.
2.5. Enzyme-linked immunosorbent assay (ELISA)
The specific antibody response (IgM) of diploid and triploid Atlantic
salmon to Aeromonas salmonicida was measured in serum samples using
a modified version of the indirect ELISA method described by Adams
et al. [52]. Ninety-six well microplates (Immulon 4HBX, Fisher Scien-
tific, UK) were coated with 0.001% (w/v) poly-L-lysine (P8920, Sigma-
Aldrich, USA) in coating buffer (50 μl well−1) for 60 min before being
washed twice with low salt wash buffer (LSWB: 0.02 M Tris, 0.38 M
NaCl, 0.05% Tween 20). Whole cell A. salmonicida ‘Hooke’ strain
(1 × 108 bacteria ml−1) was then added (100 μl well−1) and the plates
incubated overnight at 4 °C. Following this, 0.05% (v/v) glutaraldehyde
(G6403, Sigma-Aldrich, USA) in PBS was added to the antigen (50 μl
well−1) and the plates incubated for a further 20 min at room tem-
perature (RT). Plates were then washed a further 3 times with LSWB
and post-coated with 3% (w/v) casein (250 μl well−1) for 2 h at RT to
block non-specific binding sites. The post-coat was discarded before the
addition of serum samples. Serum samples were diluted 1:50 with PBS,
added to the microplates along with PBS in the negative and positive
control wells (100 μl well−1) and incubated overnight at 4 °C. The
microplates were washed with high salt wash buffer (HSWB: 0.02 M
Tris, 0.5 M NaCl, 0.1% Tween 20), with a 5 min incubation on the last
wash. Microplates were then incubated for 1 h at RT with mouse anti-
Atlantic salmon IgM monoclonal antibody (F11, Aquatic Diagnostics
Ltd., University of Stirling, Stirling, UK), diluted 1:33 with PBS (100 μl
well−1). This is with the exception of the positive control wells which
were incubated with rabbit anti-A. salmonicida polyclonal antibody
(Aquatic Vaccine Unit, University of Stirling, Stirling, UK), diluted
1:1000 in PBS. The HSWB washes were then repeated before conjugates
(anti-mouse IgG-HRP, A4416, Sigma-Aldrich, USA; anti-rabbit IgG-
HRP, A6154, Sigma-Aldrich, USA), diluted 1:4000 with conjugate
buffer, were added for 1 h (100 μl well−1). The HSWB washes were
repeated and the reaction was developed with chromogen in substrate
buffer (100 μl well−1). The reaction was stopped with 2 M H2SO4 (50 μl
well−1) after 10 min then the absorbance was measured at 450 nm and
values expressed as optical density (OD). The OD values for negative
control wells were then multiplied by 3 and samples were considered
positive if higher than this value.
2.6. Statistical analysis
Minitab software version 16 (Minitab Inc., Pennsylvania) was used to
perform basic descriptive statistics and comparisons using a significance
level of 5% (p = 0.05). Prior to analysis, datasets were checked for
normality using the Anderson-Darling test. Mortality and vertebral de-
formity data as percentages were arcsine transformed for normality. Non-
parametric tests were utilised if normal distribution was not achieved. For
mortality, non-parametric Kruskal-Wallis and Dunn's multiple comparison
post-hoc test were utilised (InStat. GraphPad Software, San Diego). For
adhesion and melanin scores, ordinal logistic regression (OLR) was per-
formed, with Vaccine Group A selected as the reference group for treat-
ment analysis and diploids as the reference group for ploidy analysis.
Antibody response, vertebral deformities and TGC were analysed using a
GLMmanipulated into a two-way ANOVA, with ploidy and vaccine group
considered fixed factors and tank considered as a random factor. Post-hoc
analyses were carried out using Tukey's multiple comparison tests with
values considered significantly different at p-values<0.05. Weight,
length and condition factor were analysed using Analysis of Covariance
(ANCOVA), with ploidy and vaccine group considered fixed factors, tank
a random factor and weight at vaccination set as a covariate. Again,
Tukey's multiple comparison test was used for post-hoc analysis.
Statistical differences in the localisation of deformed vertebrae (%) be-
tween ploidy for each vertebral region were analysed by a one-way
ANOVA. Regression analysis to detect linearity between adhesion score
severity and TGC in both fresh- and seawater was carried out. Parallelism
statistics were also performed using Excel (ANCOVA, Microsoft Office
2013, Washington, USA) to determine ploidy differences between the
gradient of regression slopes.
3. Results
3.1. Mortality
Throughout the freshwater phase of the experiment (Sept to Nov
2016), mortality was less than 3% in all the groups, with no significant
Table 2
Scoring scheme for post-vaccination visceral melanin deposits [49].
Score Visual appearance of abdominal cavity
0 No melanin in the abdominal cavity
1 Some faint melanin or small spots affecting small of the viscera
2 Moderate amounts on or within one or more organs
3 Extensive melanin deposits on viscera
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differences observed (Table 3A). In seawater (Nov 2016 to Jan 2018),
mortality remained below 10% in the vaccine groups for both ploidy,
with the exception of the triploid Dx2 group which experienced 16.8%
mortality (Table 3B). Again, there was no significant effect of ploidy or
vaccine on the mortality observed.
3.2. Antibody response
The antibody responses (specific IgM to A. salmonicida) of fish in-
jected with a vaccine (Groups B, C, D, Dx2) were all positive (Fig. 2),
while the antibody response of Group A (PBS) was negative. No sig-
nificant effect of ploidy on antibody response was observed. Vaccine
group had a significant effect on antibody response, with diploid and
triploid Group A showing significantly lower antibody response than
the other 4 groups, with the exception of the triploid Dx2 group.
3.3. Adhesions and melanin
In comparison to the “reference group” (Group A) at both smolt and
harvest, the likelihood that fish would experience “3” and “4” adhesion
scores increased as vaccine group went from Group B to Group Dx2
(smolt: OLR coefficient = −4.8, −6.6, −7.1, −8.1, p = 0.000; har-
vest: OLR coefficient = −3.1, −4.5, −4.9, −6.3, p = 0.000) (Table 1;
Fig. 3A and B). In this regard, lower scores (0–1) were more prevalent
in Groups A and B while higher scores (2–4) were more prevalent in
Groups C, D and Dx2.
In terms of ploidy differences at smolt, using diploids as the “re-
ference group” suggested that higher adhesion scores were more likely
to occur in triploids (OLR coefficient = 0.5; p = 0.004). This is evident
in Fig. 3A as triploids present increased prevalence of “3” scores over
the diploids, particularly in Group Dx2 (triploid 34.9%; diploid 21.3%).
Conversely at harvest, triploids were not more likely to have higher
scores than diploids (OLR coefficient = 0.05; p = 0.697). This is evi-
dent in Fig. 3B with triploids presenting lower prevalence of “3” (range:
2.1–33.5%) and “4” (3.2%) scores than diploids (“3” range: 2.1–43.6%;
“4”: 6.4%).
In terms of melanin scores at smolt and harvest, in comparison to
the “reference group” (Group A), as group increased from Group B to
Dx2 so did the likelihood that fish would exhibit “3” scores (smolt: OLR
coefficient = −9.0, −7.8, −9.8, −11.3; p = 0.000; harvest OLR
coefficient = −2.4, −2.9, −3.2, −4.4; p = 0.000) (Table 1; Fig. 4).
Thus, lower scores (0–1) were more prevalent in Groups A and B with
higher scores (2–3) more prevalent in Groups C - Dx2.
Using diploids as the “reference group”, at both smolt and harvest
findings suggested that higher adhesion scores were more likely to
occur in triploids than diploids (smolt: OLR coefficient = 0.5,
p = 0.009; harvest: coefficient = −0.7, p = 0.000). This is evident in
Fig. 4A and 4B as triploids present increased prevalence of “3” scores
(smolt range: 2.7–39.2%; harvest range: 1.1–6.2%) compared to di-
ploids (smolt range: 6.7–29.3%; harvest range: 0–1.1%).
3.4. Growth
3.4.1. Freshwater phase
At the point of vaccination, triploids (57.7 g ± 1.8 g) were sig-
nificantly heavier than their diploid counterparts (44.2 ± 0.9 g) in all
five vaccine groups (Fig. 5A). Within both ploidy, no significant dif-
ferences were observed between vaccine groups.
At smolt, triploids (94.4 ± 1.1 g) were significantly heavier than
their diploid counterparts (81.1 ± 0.9 g) in each vaccine group
(Fig. 5B). Within diploids, Group A (86.4 ± 1.0 g) was significantly
heavier than the other groups (79.8 ± 0.9 g), with no significant
difference observed between groups B – Dx2. Similarly, triploid Group
A (102.4 ± 1.3 g) was significantly heavier than the other 4 triploid
Table 3
Mortality (%) (mean ± SEM, n = 3) in the five vaccine groups for both diploid
and triploid Atlantic salmon during the A) freshwater and B) seawater phases of
the study.
GROUP A B C D Dx2
A) Freshwater mortality (%)
Diploid 1.4 ± 0.8 2.4 ± 1.3 2.4 ± 0.5 1.0 ± 1.0 2.0 ± 2.0
Triploid 2.4 ± 1.3 0.5 ± 0.5 1.0 ± 1.0 1.9 ± 0.5 1.6 ± 0.9
B) Seawater mortality (%)
Diploid 8.4 ± 4.8 3.7 ± 1.9 5.4 ± 2.3 3.1 ± 1.9 4.4 ± 1.9
Triploid 3.1 ± 1.9 4.4 ± 2.5 7.6 ± 2.2 6.1 ± 1.9 16.8 ± 8.6
Fig. 2. Antibody (IgM) response (OD450 nm, mean ± SEM, n = 3) against
Aeromonas salmonicida at smolt in diploid (black) and triploid (grey) Atlantic
salmon subjected to different commercial vaccines. Dashed line represents the
value over which samples are considered positive. Significant differences be-
tween ploidy and vaccine group are indicated by different letters.
Fig. 3. Prevalence (%) of each adhesion score (0, 1, 2, 3, 4) at A) smolt and B)
harvest in diploid and triploid Atlantic salmon subjected to different commer-
cial vaccines.
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groups, with Group B (96.4 ± 1.1 g) significantly heavier than Groups
D (91.3 ± 1.1 g) and Dx2 (86.7 ± 1.0 g), and Group C
(95.4 ± 1.2 g) heavier than Group Dx2.
As reflected by smolt weight, ploidy and vaccine group significantly
affected freshwater TGC (vaccination to smolt) (Fig. 6A). Diploid TGC
(1.06–1.25) was significantly higher than triploids (0.85–1.11) in all
groups, with the exception of Group B (diploid 1.12 ± 0.02; triploid
1.02 ± 0.09) (Fig. 6A). Within the diploids, TGC was significantly
higher in Group A (1.25 ± 0.03) than the other four groups
(1.06–1.12). In the triploids, TGC in Group A (1.11 ± 0.05) was sig-
nificantly higher than in Groups C (099 ± 0.06), D (0.93 ± 0.06) and
Dx2 (0.85 ± 0.07). The TGC of Group B (1.02 ± 0.09) was sig-
nificantly higher than in Groups D and Dx2, with Group C TGC sig-
nificantly higher than Group Dx2.
A significant negative correlation (p = 0.02) was found between
TGC and increasing adhesion score (Fig. 7A). Regression analysis
showed that the vertical distance between the diploid and triploid
slopes was not statistically significant (p = 0.18), with parallelism
statistics indicating that slope gradient was statistically similar between
ploidy (p = > 0.05) and thus that diploids and triploids showed si-
milar responses to increasing “vaccine severity”.
At smolt, no ploidy differences were observed for K, with the ex-
ception of Group D where diploids (1.17 ± 0.01) had significantly
higher K than their triploid counterparts (1.14 ± 0.01) (Fig. 8A).
Within the diploids, K in Groups D and Dx2 (1.17 ± 0.01) was sig-
nificantly higher than Groups A (1.14 ± 0.01) and B (1.15 ± 0.01).
No significant differences in K were found between vaccine groups in
the triploids.
3.4.2. Seawater phase
In May 2017 (6 months post-transfer to seawater), triploids
(809.4 ± 14.4 g) were significantly heavier than their diploid
Fig. 4. Prevalence (%) of each melanin score (0, 1,2, 3) at A) smolt and B)
harvest in diploid and triploid Atlantic salmon subjected to different commer-
cial vaccines.
Fig. 5. Weight (g) (mean ± SEM, n = 3) of diploid (black) and triploid (grey) Atlantic salmon in the five vaccine groups at A) vaccination, B) smolt (end of
freshwater), C) May 2017, D) August 2017, E) October 2017 and F) harvest (Jan 2018) Significant differences between ploidy and vaccine groups are indicated by
different letters.
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counterparts (608.4 ± 12.6 g) in all five vaccine groups (Fig. 5C).
Within the diploids, Groups A (645.2 ± 13.1 g), B (630.2 ± 11.3 g)
and C (610.9 ± 12.1 g) were significantly heavier than Groups D
(590.6 ± 12.1 g) and Dx2 (565.6 ± 147 g). Triploid fish in Group A
(883.3 ± 14.8 g) were significantly heavier than those in Group Dx2
(729.7 ± 14.2 g). In August 2017, triploid weight (1962.6 ± 41.8 g)
remained higher than that of the diploids (1646.4 ± 45.6 g), sig-
nificantly so in Group A (triploids 2119.1 ± 39.9 g; diploids
1728.9 ± 48.9 g) (Fig. 5D). Within the diploid group, Group B
(1728.8 ± 40.1 g) was significantly heavier than Group Dx2
(1505.1 ± 46.7 g). In the triploids, Groups A and B (2088.9 ± 46.2 g)
were significantly heavier than Groups D (1857.7 ± 37.6 g) and Dx2
(1761.4 ± 48.5 g).
In October 2017 (11 months post-transfer to seawater), weight was
not significantly affected by ploidy or vaccine group (Fig. 5E). At har-
vest (Jan 2018), diploids (4917.2 ± 137.3 g) weighed significantly
more than their triploid counterparts (4579.4 ± 141.1 g) in all groups,
except Group B (diploid 5013.2 ± 151.5 g; triploid
4886.2 ± 145.3 g) (Fig. 5F). Within both ploidy, vaccine group did not
have a significant effect on weight.
Seawater TGC (smolt to harvest) was higher in diploids
(2.98 ± 0.06) than in triploids (2.83 ± 0.03) for all vaccine groups,
significantly so in Group C (diploids 3.02 ± 0.03; triploids
2.84 ± 0.02) (Fig. 6B). No correlation (p = 0.82) between TGC and
adhesion score was found (Fig. 7B). Regression analysis showed that the
vertical distance between the diploid and triploid slopes was not sta-
tistically significant (p = 0.07), with parallelism statistics (ANCOVA)
revealing no significant difference in gradient (p > 0.05) between
ploidy, which would indicate similar response to vaccination between
ploidy.
At harvest, K in diploids (1.54 ± 0.01) was higher than their re-
spective triploids (1.30 ± 0.02), significantly so in Group A (diploids
1.50 ± 0.01; triploids 1.24 ± 0.01) (Fig. 8B). No significant effect of
vaccine groups was observed in both ploidy, vaccine group did not have
a significant effect on K.
3.5. X-ray radiography for vertebral deformities
Vertebrae number did not differ significantly between diploids
(57.8 ± 0.5) and triploids (57.7 ± 0.6) (p = 0.28). Prior to vacci-
nation (“baseline”), the prevalence of moderate-severe deformities
(> 6 dV) was not significantly different between ploidy (diploids
2.0 ± 1.8%; triploids 6.0 ± 2.5%) (data not shown). Prevalence did
not change from “baseline” to smolt (diploid 0.8 ± 0.5%; triploid
12.3 ± 4.5%) (p > 0.05), while it increased significantly from
“baseline” to harvest in both diploids (15.9 ± 1.9%; p = 0.002) and
triploids (34.9 ± 5.9%; p = 0.008).
At smolt, ploidy significantly affected the prevalence of ≥6 dV (p =
0.00) with triploids consistently showing higher deformity prevalence
than diploids, significantly so in Groups C, D and Dx2 (diploids 0%,
triploids 10.7–17.2%) (Fig. 9A). Within both diploids and triploids at
smolt, vaccine group did not significantly affect the prevalence of fish
exhibiting ≥6 dV (p = 0.79).
Similarly, at harvest, triploids showed consistently higher deformity
prevalence than diploids, although only significantly so in Group A
Fig. 6. Thermal growth coefficient of diploid (black) and triploid (grey)
Atlantic salmon in the five vaccine groups during A) freshwater (vaccination to
smolt) and B) seawater (smolt to harvest) (mean ± SEM, n = 3). Significant
differences between ploidy and vaccine group are indicated by different letters.
Fig. 7. Linear regression of relationship between adhesion score and TGC in
diploid (black) and triploid (grey) Atlantic salmon for the A) freshwater and B)
seawater phases of the experiment.
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(diploid 3.0 ± 1.5%; triploid 36.7 ± 6.7%) (Fig. 9B). In addition,
within diploids, vaccine group had a significant effect on deformity
prevalence with Group A exhibiting significantly lower deformity than
Groups B (16.7 ± 1.7%), C (26.7 ± 4.4%) and Dx2 (20.0 ± 0.0%).
No significant vaccine group effect was observed in the triploids.
Within the diploids, the prevalence of fish with ≥6 dV was sig-
nificantly higher at harvest than at smolt in all vaccine groups (smolt
0.8 ± 0.5%, harvest 15.9 ± 1.9%), with the exception of Group A.
Similarly, there was increased prevalence of fish with ≥6 dV from
smolt to harvest in triploids. This was significant in Groups A (smolt
10.7 ± 2.7%; harvest 36.7 ± 6.7%) and C (smolt 10.7 ± 4.8%;
harvest 43.7 ± 1.9%).
Deformed vertebrae (dV) were observed in all four spinal regions in
both ploidy at smolt and harvest (Fig. 10A and B). At smolt, triploids
consistently had more deformed dV than diploids, significantly so in the
caudal trunk (R2) (p = 0.010; triploids 6.23 ± 0.49%, diploids
0.83 ± 0.2%) (Fig. 10A). Triploids had the highest prevalence of dV in
R2 while diploids showed the highest prevalence of dV in the cranial
trunk (R1).
At harvest, triploids continued to exhibit more dV than diploids,
again significantly in R2 (p= 0.008; triploids 13.86 ± 0.71%, diploids
5.53 ± 1.11%), as well as in the tail region (R3) (p = 0.048; triploids
16.97 ± 0.21%, diploids 8.69 ± 1.88%) (Fig. 10B). The region with
the highest deformity prevalence in both ploidy was R3, with increased
prevalence remaining in R2.
In terms of time changes, the prevalence of dV in R3 in diploids
significantly increased from smolt to harvest (p = 0.046), with no
significant time changes for the other regions. For triploids, there was a
significant effect of time in all four regions, with higher prevalence
observed at harvest than at smolt (p = 0.001–0.027).
In the diploids groups at smolt, while the prevalence of fish with
≥6 dV was low (0–2.7%), the most predominant vertebral deformity
type in all groups was fusions (0.7–1.9%) followed by compressions
(0.29–0.49%) (Fig. 11A). The most common type of fusion pathology
was complete fusion (type 7) (0–1.5%) followed by fusion centre (type
8) (0–0.7%). In terms of compressions, the most prevalent type was
compression and reduced intervertebral space (type 3) (0–0.4%) fol-
lowed by one-sided compression (type 5) (0–0.3%). By harvest, the
prevalence of all vertebral deformity types in all diploid vaccine groups
had increased. A clear shift in deformity type prevalence was found at
harvest in Groups B to Dx2, with compressions occurring most fre-
quently (0.3–18.3%), followed by decreased intervertebral space
(2.1–8.8%) and fusions (0–1.4%). The most common type of compres-
sion pathology was compression and decreased intervertebral space
(0–15.4%), followed by one-sided compression (0.1–1.1%). In terms of
fusion, the most prevalent type was complete fusion (0–0.9%), followed
by compression and fusion (type 6) (0–0.9%).
As with the diploids at smolt, the most predominant vertebral de-
formity type in all triploid groups was fusions (5.3–9.2%), followed by
compressions (2.8–4.6%) (Fig. 11B). The most common type of fusion
pathology was fusion centre (3.0–4.9%) followed by complete fusion
(0.7–2.8%). In terms of compressions, the most prevalent type was one-
sided compression (2.7–4.4%), followed by compression without X
structure (type 4) (0–0.4%). By harvest, the prevalence of all vertebral
deformity types had increased from that exhibited at smolt. Compres-
sions (12.1–20.7%) were found to be most prevalent deformity type in
all of the triploid groups at harvest, followed by fusions (9.5–12.4%).
The most common type of compression pathology was one-sided com-
pression (9.9–11.9%), followed by compression and reduced
Fig. 8. Condition factor (K) (mean ± SEM, n = 3) of diploid (black) and
triploid (grey) Atlantic salmon in the five vaccine groups at A) smolt and B)
harvest. Significant differences between ploidy and groups are indicated by
different letters.
Fig. 9. Prevalence (%) of individuals with 6 or more deformed vertebrae (dV)
in diploid (black) and triploid (grey) Atlantic salmon at A) smolt and B) harvest
(mean ± SEM, n = 3). Significant differences between ploidy and vaccine
groups are indicated by different letters.
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intervertebral space (0.6–9.1%). In terms of fusion, the most prevalent
type was fusion centre (3.9–8.2%), followed by complete fusion
(0.7–4.6%).
4. Discussion
Vaccination, an essential tool for disease prevention, is now
common practice in commercial salmonid aquaculture [53]. However,
despite the desire to employ triploid Atlantic salmon in full-scale pro-
duction to overcome pre-harvest maturation, published studies on tri-
ploid response to vaccination remain scarce. Considering this, the
current study compared the response of diploid and triploid Atlantic
salmon to commercially available vaccines, in terms of performance
and the occurrence of side-effects.
Mortality during freshwater (vaccination to smolt) and seawater
(smolt to harvest) generally remained below 10% in all vaccine groups,
with no significant effect of ploidy. Comparable ploidy mortality con-
curs with previous research into triploid vaccination [42,43] as well as
recent grow-out studies [33,45,54–57]. It can be suggested that this is
linked to advances in triploid nutrition [31–33] and environmental
requirements [30,35,36,58,59]. However, higher mortality was ob-
served in the triploid Dx2 group (16.8%) in seawater due to increased
mortality in one of the triplicate cages (34.2% versus 7.7 and 8.6%).
Suggestions to the cause of mortality cannot be drawn as no disease
outbreaks were observed, and no nuisance seal activity was reported.
The measurement of antibody levels following the vaccination of
Atlantic salmon is indicative of the immune response [60]. While the
vaccines in this study contained a combination of antigens, A. salmo-
nicida was used as it was the common antigen in all groups and has
previously elicited a positive IgM response in salmonids [48,61,62].
Ploidy did not significantly affect antibody response to A. salmonicida, a
finding consistent with previous studies in Atlantic salmon, ayu (Ple-
coglossus altivelis) and chinook salmon (Oncorhynchus tshawytscha)
[38,63,64]. Vaccine group, however, did significantly affect antibody
response. The vaccine-containing groups B, C, D and Dx2 showed a
positive antibody response, which was significantly higher than the
negative antibody response elicited by the PBS-control group (A). This
is supported by previous research in which vaccination elicited an in-
creased antibody response compared to sham-injections [38,61,64,65].
However, the antibody responses obtained in all the vaccine groups in
the current study were lower than expected when compared to previous
studies [60,61]. Using a whole cell A. salmonicida ELISA, 1/50 serum
dilution and sampling at 7 weeks post-vaccination (conditions as per
the current study), Erdal and Reitan [61] found that vaccinated fish
exhibited an average antibody response of 1.16, three times greater
than this study (diploid range 0.19–0.46; triploid range 0.22–0.42). The
onset of protection for the vaccines utilised in this study is documented
to occur between 520 and 600 °D post-vaccination so it could be sug-
gested that, due to sampling occurring at 622 °D post-vaccination, the
response was still in the early stages of development. Additionally,
Erdal and Reitan [60] used constant 12 °C, while water temperature in
this trial decreased from 16 °C at vaccination to 9 °C at sampling. As
such, the decreasing temperature could have slowed down antibody
development and a greater response may have been observed with
higher and/or constant water temperature [66,67].
Intra-abdominal adhesions are the most common side-effect of the
vaccination process and have the potential to cause severe muscle da-
mage and carcass downgrading at harvest [18,22,43]. At smolt, results
from ordinal logistic regression suggested that triploids were more
likely to experience higher adhesion scores (“3” or “4”) than diploids.
This finding concurs with a previous study assessing vaccination in S0+
Fig. 10. Average prevalence (all vaccine groups) of deformed vertebrae within
each spinal region (%) in diploid (black) and triploid (grey) Atlantic salmon at
A) baseline, B) smolt and C) harvest (mean ± SEM, n = 3). Asterisk (*) de-
notes significant differences between ploidy within vertebral regions.
Fig. 11. Prevalence (%) of different vertebral deformity pathology types (de-
creased intervertebral space, compression, fusion, radiodense, symmetry and
other) within the deformed population with ≥6 dV of A) diploid and B) triploid
Atlantic salmon at smolt and harvest.
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smolts, which found significantly higher adhesion scores in triploids
[43]. By harvest, triploids were not more likely to experience higher
adhesion scores than diploids, a finding which is supported by studies
in S1+ smolts [38] and harvest-size diploid and triploid Atlantic
salmon [68] which found similar adhesion scores between ploidy.
Taking these findings into account, further studies are recommended to
determine the reason why triploid Atlantic salmon may be more prone
to higher adhesion scores and to assess the interaction of temperature,
vaccine type (antigens, adjuvants, manufacturer), vaccine dose and
ploidy on the occurrence of adhesion.
At smolt and harvest, vaccine group significantly affected adhesion
score in both diploids and triploids, with scores increasing as antici-
pated. This concurs with a previous study which showed increased
adhesion scores with increasing antigen number [69]. Furthermore,
while adhesion severity increased as expected, patterns remained si-
milar over time. This is supported by Berg et al. [70] who found that
adhesion scores in Atlantic salmon increased quickly following vacci-
nation and then remained stable until harvest. The highest adhesion
scores (“3” and “4”) were consistently found in the “accidental double-
dose” group (Dx2) while the lowest (“0”) occurred in the PBS-control
group (A). This demonstrates the negative effect that can be caused by
improper vaccine administration and highlights the necessity for op-
timal vaccination strategies and practices [67].
The deposition of melanin in the viscera and musculature can result
in down-grading at harvest [71]. Melanin deposits were observed in the
viscera at smolt and harvest, with ordinal logistic regression suggesting
that triploids were more likely to experience increased prevalence (%)
of higher scores. This finding concurs with Larsen et al. [71], whose
study showed increased prevalence of melanin deposits post-vaccina-
tion in triploid S0+ smolts. However, as Larsen et al. [71] did not score
the severity of the melanin deposits, it is unclear how the prevlance of
each score changed within their populations. As the current study and
Larsen et al. [71] represent the only records of melanisation in triploids
post-vaccination, further investigations are necessary to fully elucidate
ploidy differences in the occurrence of melanin deposits post-vaccina-
tion. At smolt and harvest, melanin deposits were observed in the vis-
cera of all vaccine groups in both ploidy. This concurs with previous
findings which observed melanin deposits occurring in both vaccinated
and sham-vaccinated Atlantic salmon [71,72]. However, it should be
noted that higher melanin scores occurred in the vaccine-injected
groups (B – Dx2) than in the PBS-control group (A), which, again,
concurs with previous research [72].
The growth performance of triploids continues to be debated
[45,55,73,74], with triploid growth following vaccination relatively
uncharacterised. In this study, triploids in each vaccine group were
consistently heavier than their respective diploids until October 2017,
with diploids significantly heavier by harvest (January 2018). This
concurs with results from other triploid vaccination studies in that,
regardless of vaccination or smolt regime, triploids were heavier than
diploids in freshwater and initial seawater stages (current study
+19.3%; Fraser et al. [42], +10.6%; Fraser et al. [43], +8.2%) but
diploids were heavier by harvest (current study +7.02%; Fraser et al.
[43], +8.6%). In addition, the current findings also support perfor-
mance studies where triploids were heavier in freshwater and early
seawater stages but lost their weight advantage by harvest
[33,35,39,45,56,75]. As previous studies in triploid Atlantic salmon
have reported a negative link between high temperatures (≥12 °C) and
feed intake and growth [35,36], it could be suggested that the high
water temperature experienced in the current study from July to Oc-
tober 2017 (12.9–15.4 °C), negatively impacted triploid growth.
Vaccine group significantly affected weight in both ploidy, with
weight consistently highest in Group A (PBS) and lowest in Group Dx2
(double-dose). This supports previous studies which found reduced
growth in vaccinated fish compared to unvaccinated controls
[18,42,43,69,70,76]. Combining increased adhesion scores and re-
duced growth in the Group Dx2 fish clearly demonstrates the negative
effect of incorrect vaccine administration on production.
In terms of growth rate, TGC in triploids was lower than diploids at
both smolt and harvest which is indicative of a slower growth rate in
triploids. This finding agrees with previous studies [75,77,78] but
contrasts with studies showing improved freshwater growth [28,45,55].
Knowing that triploids were heavier than diploids at vaccination sug-
gesting faster growth rate from first feeding, reduced TGC in triploids
may be the result of high temperatures (14–16 °C) experienced both
pre- and post-vaccination. This is supported by Sambraus et al. [35]
whose study found that increased temperatures (> 15 °C) negatively
affected feed intake in triploids and subsequently reduced growth. In
seawater, lower triploid TGC is supported by previous studies where the
early growth advantage experienced by triploids is lost
[45,55,68,75,79]. With few studies showing that triploid growth can be
sustained at a higher rate through to harvest [28,33], it is re-
commended that further work be undertaken to fully optimise the
rearing of triploids in seawater to achieve maximum growth potential.
Freshwater TGC was negatively correlated with adhesion score se-
verity, and thus vaccine group, in both ploidy which concurs with
previous studies [68,69]. During the seawater phase (smolt – harvest),
regression analysis showed that the negative impact of adhesion score
on TGC was reduced. This could be linked to the earlier observation
that adhesion scores did not increase significantly between smolt and
harvest and, as a result, seawater growth was able to continue “nor-
mally”. This is an encouraging finding for salmon producers in that,
although initial vaccination and adhesion development may impact
growth, the overall effect diminishes with time thus allowing fish to
perform normally.
Vertebral deformities have previously been reported in farmed and
wild salmon with potential to cause welfare concerns and economic
losses for the salmon industry [21]. For the purpose this study, only fish
presenting 6 or more dV were considered for analysis, a decision which
stems from work by Hansen et al. [44] suggesting that fish exhibiting
less than 6 dV would not be significantly affected in terms of perfor-
mance or welfare. Radiographic deformity (%, ≥6 dV) at smolt and
harvest was significantly affected by ploidy, with triploids consistently
exhibiting higher levels than diploids. This supports previous studies
using S0+ Atlantic salmon, which found a higher deformity prevalence
in triploids compared to their diploid siblings [32–34]. However, in
terms of deformity at smolt, findings are in contrast to Fraser et al. [43]
whose study found S0+ triploid smolts with equal or lower deformities
than diploids. Considering the proposed relationship between growth
rate and the prevalence of skeletal deformity [44,45], the authors hy-
pothesised that elevated temperatures in S0+ smolt production (16 °C
for 42 days) impeded growth rates in triploids and as such, alleviated
the risk of deformity. When TGC between vaccination and smolt
transfer is calculated for S0+ smolts in the Fraser et al. [43] study, this
hypothesis can be supported as triploid TGC (average 0.83) was lower
than expected for this life-stage (~1.40, Liu et al. [80]). While an ex-
tended period of high temperature in the current study may have re-
sulted in the same pattern, temperature decreased post-vaccination and
freshwater TGC in triploids (0.88–1.12) was higher than that of Fraser
et al. [43] and closer to expected [80]. So, despite lower TGC than
diploids, triploids in the current study were still growing fast which
may explain their significantly increased prevalence of vertebral de-
formities. To fully confirm this, it is recommended that research be
undertaken to assess the effect of a range of high water temperatures for
varying durations, in combination with smolt regimes and vaccination,
on the development of vertebral deformities in triploid Atlantic salmon.
At smolt and harvest, vaccine group did not significantly affect
radiological deformity in diploids and triploids, a finding which concurs
with Fraser et al. [43] who found similar levels of deformity in un-
vaccinated and vaccinated Atlantic salmon. Moreover, the finding
would appear to refute the suggestion that the development of vertebral
deformities can be aggravated through the vaccination process [21]. In
both ploidy, deformity prevalence increased over time from smolt to
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harvest which concurs with previous studies [32,33]. Elevated seawater
temperatures prior to harvest (July–October 2017; 12.9–15.4 °C) may
have aggravated deformity prevalence but further studies would be
required to elucidate the effect of a seawater “temperature spike” on the
prevalence of vertebral deformities.
Deformed vertebrae were found in the four vertebral regions in both
ploidy at smolt and harvest. Within R2 at smolt, and R2 and R3 at
harvest, triploids had significantly higher prevalence of dV than di-
ploids which supports previous reports [32,33]. In both ploidy at smolt,
R2 had the highest deformity prevalence which concurs with previous
studies indicating this as the most affected vertebral region during
freshwater growth [32,54,81,82]. By harvest, the region exhibiting the
highest deformity prevalence in both ploidy had shifted from R2 to R3,
again supporting previous research [27,32,33,43,83]. The types of dV
pathology within the deformed population were also assessed. At smolt
and harvest, fusions (type 6–8) and compressions (type 2–5) were the
most prevalent pathology types in all ploidy vaccine groups in line with
previously published studies [30,32,43,45,81]. Collectively, deformity
results from the current study suggest that ploidy, in conjunction with
other factors (e.g. temperature profile) rather than vaccine, is predis-
posing triploids to increased risk of vertebral deformities.
5. Conclusions
This study showed that triploids respond as well as diploids to
vaccination. Similar antibody responses indicate that all the vaccines
assessed would be as effective in protecting triploids as diploids fol-
lowing disease challenge. Ploidy significantly affected both adhesion
and melanin scores, suggesting that triploids may be prone to higher
scores than diploids, although further studies would be required to fully
elucidate these differences. The significant weight difference main-
tained by triploids throughout freshwater and early seawater was lost at
harvest which suggests that further studies are required to establish the
full growth potential of triploids and determine optimum farming lo-
cations for the deployment of triploid Atlantic salmon. The significant
effect of vaccine group and adhesion score on TGC highlights the need
for accurate commercial vaccination procedures. It should be noted that
Group Dx2 is not commercial practice and was used only to demon-
strate the negative effect of “accidental double-dosing” on fish perfor-
mance and welfare. As in previous studies, vertebral deformities re-
mained higher in triploids than in diploids. This indicates the need for
further studies to advance the current knowledge of triploid nutrition
and thermal requirements and thus fully elucidate the issue of triploid
vertebral deformities. Overall, the findings support the use of com-
mercial vaccines in triploid Atlantic salmon, and continue to support
the suitability of triploids for commercial-scale salmon production.
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